Microcompartmentation at the mitochondrial surface Brdiczka, D.; Knoll, G.; Riesinger, I.; Weiler, U.; Klug, G.; Benz, R.; Krause, J.
The Prince Edward Island Bioscience cluster Casper, S.; Krause, J.; MacNevin, A.
Characterization of Muscarinic Receptor in Guinea Pig Uterus Smooth Muscle Doods, H. N.; Willim, K.; Krause, J.
Catabolism of tissue-type plasminogen activator (t-PA), its variants, mutants and hybrids Krause, J.
Hepatic uptake of tissue-type plasminogen activator is saturable Krause, J.; Tanswell, P.
Properties of molecular variants of tissue-type plasminogen activator Krause, J.; Tanswell, P.
Optimizing Productivity in a Matrix Structure Krause, J.
Purification and characterization of the pore forming protein of yeast mitochondrial outer membrane Ludwig, O.; Krause, J.; Hay, R.; Benz, R.
Profound and sustained inhibition of platelet aggregation by fradafiban, a nonpeptide platelet glycoprotein IIb/IIIa antagonist, and its orally active prodrug, lefradafiban, in men Müller, T. H.; Weisenberger, H.; Brickl, R.; Narjes, H.; Himmelsbach, F.; Krause, J.
Pharmaco-dynamics and-kinetics of BIBU 52, a platelet glycoprotein (GP) IIb/IIIa antagonist, and its orally active prodrug BIBU 104 in man Müller, TH; Weisenberger, H.; Brickl, R.; Kirchner, M.; Narjes, H.; Himmelsbach, F.; Guth, B.; Krause, J.
Tolerability and platelet fibrinogen receptor occupancy (FRO) after oral treatment with BIBU 104 xx in healthy volunteers Narjes, H.; Weisenberger, H.; Muller, TH; Deichsel, G.; Krause, J.
Endocytosis of the recombinant tissue plasminogen activator alteplase by hepatic endothelial cells. Seydel, W.; Stang, E.; Roos, N.; Krause, J.
Tissue-type plasminogen activator and ovalbumin show colocalization after endocytosis in hepatic cells. Stang, E.; Krause, J.; Berg, T.; Roos, N.
Endocytosis and intracellular processing of tissue-type plasminogen activator by rat liver cells in vivo. Stang, E.; Krause, J.; Seydel, W.; Berg, T.; Roos, N.
Evidence for carbohydrate-independent endocytosis of tissue-type plasminogen activator by liver cells. Stang, E.; Roos, N.; Schlüter, M.; Berg, T.; Krause, J.
Nonlinear pharmacokinetics of tissue-type plasminogen activator in three animal species and isolated perfused rat liver. Tanswell, P.; Heinzel, G.; Greischel, A.; Krause, J.
Pharmacokinetics and isolated liver perfusion of carbohydrate modified recombinant tissue-type plasminogen activator Tanswell, P.; Schlüter, M.; Krause, J.
Pharmacokinetics and hepatic catabolism of tissue-type plasminogen activator. Tanswell, P.; Seifried, E.; Stang, E.; Krause, J.
Balancing R&D and Commercialization Teams to Maximize Early Market Entry Krause, J.
Aligning R&D and Commercial to Increase Productivity Krause, J.
Strategic macro-environmental factor analysis for entry into the fish vaccines market in India Pallapothu, Mahendra Kumar; Krause, Juergen
Case study of interprovincial variations in patient access to Oncology drugs Ballem, Katherine H. D.; Krause, Juergen
Porin pores of mitochondrial outer membranes from high and low eukaryotic cells De Pinto, V.; Ludwig, O.; Krause, J.; Benz, R.; Palmieri, F.
Different neuropeptsde Y receptor subtypes in rat and rabbit vas deferens Doods, H. N.; Krause, J.
Alterations in liver mitochondrial function as a result of fasting and exhaustive exercise. Klug, G. A.; Krause, J.; Ostlund, AK; Knoll, G.; Brdiczka, D.
Localisation of fluorescence-labelled recombinant tissue-type Plasminogen activator (rt-PA) on thrombi in vitro Krause, J.; Deutsch, H.
Neuropeptide Y1 subtype pharmacology of a recombinantly expressed neuropeptide receptor. Krause, J.; Eva, C.; Seeburg, P. H.; Sprengel, R.
Localisation of fluorescence labelled recombinant tissue-type plasminogen activator (rt-PA) on thrombi in vitro Krause, J.; Deutsch, H.
The degree of coupling of oxidative phosphorylation is varied physiologically Krause, J.; Klug, G.; Brdiczka, D.
Enrichment and biochemical characterization of boundary membrane contact sites from rat-liver mitochondria. Ohlendieck, K.; Riesinger, I.; Adams, V.; Krause, J.; Brdiczka, D.
The binding of glycerol kinase to the outer membrane of rat liver mitochondria Östlund, A. K.; Göhring, U.; Krause, J.; Brdiczka, D.
BIBP 3226, the first potent and selective non-peptide Y1 receptor antagonist Rudolf, K.; Eberlein, W.; Engel, W.; Beck-Sickinger, AG; Dollinger, H.; Esser, F.; Schnorrengerg, G.; Mihm, G.; Wieland, H. A.; Entzeroth, M.; Wienen, W.; Krause, J.; Doods, H. N.
Characterization of the receptor mediating the hepatic catabolism of t-PA Seydel, W.; Hoffmann, H.; Krause, J.
Endocytosis and intracellular processing of t-PA by rat liver cells Seydel, W.; Hoffmann, H.; Krause, J.
Saturability of clearance of t-PA in three animal species and isolated perfused rat liver Tanswell, P.; Heinzel, G.; Greischel, A.; Seydel, W.; Krause, J.
Nonlinear pharmacokinetics and isolated liver perfusion of carbohydrate-modified tissue-type plasminogen activator Tanswell, P.; Schluter, M.; Krause, J.
The structure and function of the pore in the mitochondrial external membrane / Untersuchungen zur Struktur und Funktion der Pore in der Mitochondrialen Aubenmembran Krause, J.
Die molekularbiologischen Eigenschaften des Gewebetyp-plasminogenactivators und seiner Varianten Tanswell, P.; Krause, J.
Hepatic Endocytosis of Tissue-Type Plasminogen Activator with Special Reference to the Sinusoidal Cells Wisse, E.; Knook, D. L.; ,
Pharmacokinetics of Human Tissue-Type Plasminogen Activator Tanswell, P.; Seifried, E.; Krause, J.
Subscribe to Juergen Krause's citation feed